Q2 2020 DURECT Corp Earnings Call Transcript
Greetings, and welcome to the DURECT Corporation Second Quarter 2020 Earnings Conference Call.
(Operator Instructions)
As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, Mr. Mike Arenberg, Chief Financial Officer. Please go ahead, sir.
Good afternoon, and welcome to our second quarter 2020 earnings conference call. This is Mike Arenberg, Chief Financial Officer of DURECT Corporation. I'll provide a brief review of our financial results; and then Jim Brown, our President and CEO, will provide an update on our program. We will then open up the call for a question-and-answer session.
Before beginning, I would like to remind you of our safe harbor statement. During the course of this call, we may make forward-looking statements regarding DURECT's products and development, expected product benefits, our product development plans, future clinical trials or projected financial results. These forward-looking statements
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |